Semaglutide's reach expands, with a UK pill option and new signals of slowed aging markers in HIV patients. However, its rapid mainstreaming has fueled 8,000 poison control calls by 2023 due to dosing errors and raises questions about oversight in online prescriptions, per a Yale study. Watch for NICE's UK approval and regulatory responses to telehealth practices.